TY  - GEN
AU  - Savès,M
AU  - Raffi,F
AU  - Clevenbergh,P
AU  - Marchou,B
AU  - Waldner-Combernoux,A
AU  - Morlat,P
AU  - Le Moing,V
AU  - Rivière,C
AU  - Chêne,G
AU  - Leport,C
TI  - Hepatitis B or hepatitis C virus infection is a risk factor for severe hepatic cytolysis after initiation of a protease inhibitor-containing antiretroviral regimen in human immunodeficiency virus-infected patients. The APROCO Study Group
SN  - 0066-4804
PY  - 2001///0215
KW  - AIDS-Related Opportunistic Infections
KW  - immunology
KW  - Adult
KW  - Alanine Transaminase
KW  - metabolism
KW  - Female
KW  - HIV Infections
KW  - complications
KW  - HIV Protease Inhibitors
KW  - adverse effects
KW  - HIV-1
KW  - Hepacivirus
KW  - Hepatitis B
KW  - etiology
KW  - Hepatitis B virus
KW  - Hepatitis C
KW  - Hepatocytes
KW  - drug effects
KW  - Humans
KW  - Liver
KW  - pathology
KW  - Male
KW  - Risk Factors
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1128/AAC.44.12.3451-3455.2000
ER  -